Jan
11

A Review of the Studies on TSH Suppression

The last medical journal article that was presented in the last course, Treating T3 Deficiency: The Evidence You Need (Part 6), stated that exogenous hyperthyroidism (TSH suppression) with thyroid hormone administration was not associated (causative) of any adverse effect. “There is no scientific evidence that the clinical impact of TSH suppression is significant.” This meta-analysis proving no harm with thyroid hormone administration (along with TSH suppression) is in direct contrast to the opinions of the other papers/authors opinions reviewed in the last course. I reviewed many papers and opinions that TSH suppression was harmful. However, I emphasized that the studies cited were all studies that reviewed baseline TSH levels in patients with Graves’ disease. Not one study was an outcome study in patients that were prescribed/treated with thyroid hormone. However, the results of all these baseline observation studies demonstrated/proved that suppressed TSH levels (in Graves’ patients) were associated with harm, sudden cardiac death, a-fib, osteoporosis, etc. The authors of the various opinion papers went on to extrapolate that thyroid hormone administration resulting in suppressed TSH levels (biochemical hyperthyroidism) was just as bad/harmful as that seen in those studies citied in patients with Graves’ disease. Nothing could be further from the truth. That which is observed in treatment trials can be completely the opposite of what is observed in baseline observation studies. Another perfect example of ODNPC.

By Deirdre Nitsche | Blog . HRT Evidence Based Literature . Thyroid
DETAIL
Aug
18

Controlling HgBA1C with Medications Does not Make Diabetes Disappear – It Lowers the Surrogate Marker HgBA1C

Although the pathophysiology is simple, the treatment and reversal of CVD and cancer is what is so confusing, complex, misunderstood, and ignored.

By Neal Rouzier | Blog . HRT Evidence Based Literature
DETAIL
Aug
06

Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients

Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients Written by Neal Rouzier, MD Recommended Pre-Reading: More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion Treatment Scenario A 59 y/o female with CVD is referred by her friend for evaluation of hypothyroidism. Laboratory tests consistently
DETAIL
Jul
29

More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion

More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion Written by Neal Rouzier, MD Recommended Pre-Reading: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients? Treatment Scenario A 45 y/o female with persistent symptoms of fatigue, low energy, depression,
DETAIL
Jul
27

If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients?

If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients? Written by Neal Rouzier, MD Recommended Pre-Reading: Treating T3 Deficiency: The Evidence You Need Treatment Scenario Your 41 y/o PCOS patient that is optimized on thyroid returns with concerns that her PMD
DETAIL
Apr
08

Treating T3 Deficiency, the Evidence You Need

I do not believe that there is any one subject in medicine that is as misunderstood, politicized, debated, denigrated, and contentious as thyroid hormone. The pharmaceutical thyroid industry has spent millions on brain-washing physicians and convincing them that thyroxine is the best and only thyroid medicine that should be utilized. So many patients have relayed to me that their PMD will no longer treat them if they continue to take Armour Thyroid. 

DETAIL
Mar
02

Meta-Analyses of the Risks, Benefits, Complications, Adverse events, and Outcomes Associated with Testosterone Replacement

One would think that the cardiovascular and endocrine worlds would embrace this as a gamechanger for preventing both diabetes and CVD.
Not so.

DETAIL
Jul
21

The 7 Hormones Everyone Should Know

An overview of DHEA, Melatonin, Pregnenolone, Thyroid, Testosterone, Estrogen, and Progesterone

DETAIL
Jul
07

Estrogen Dominance in Men

Testosterone replacement therapy has a significant role in protecting aging men’s health, including greater protection against heart disease, diabetes, and obesity. However, it naturally increases estrogen levels in men, which has brought the benefits of testosterone therapy into question.

By Worldlink Medical | Blog . Estrogen . HRT Evidence Based Literature
DETAIL
Jun
24

Transdermal vs. Oral Estrogen

While experts agree estrogen has far reaching benefits in menopausal women, researchers tend to disagree on how estrogen therapy should be administered.

By Worldlink Medical | Blog . Estrogen . HRT Evidence Based Literature
DETAIL